Techopia

Kanata-made saliva collection kits will boost COVID-testing efforts, DNA Genotek says

Company announced this week that Health Canada has given the green light to its device for emergency use, meaning labs now have access to the spit kit for COVID-19 testing.

Strong fourth quarter propels Ottawa’s BluMetric to $471K profit in fiscal 2020

Cleantech firm booked $10.4 million in revenues in the fourth quarter ​– up substantially from the $6.6 million it generated in the same period a year earlier.

Macadamian boss ‘handing off the keys’ after Gatineau software firm bought by U.S. company

Co-founder Fred Boulanger to step aside now that local tech enterprise is under the ownership of Nashville-based digital health-care services provider emids.

Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans

Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve a market breakthrough.

Cleantech firm Thermal Energy sees signs of hope despite major drop in Q2 revenues

Despite the steep drop in sales, the company still managed to boost its net profit to $580,000 from $385,000.

Techopia Live: Capital Angel Network investments hit $4.1M in 2020

Investor focus broadening to include more biotech, clean tech opportunities

UOttawa startup gets $4M funding boost for technology that curbs ‘freezer burn’ in stem cell tissue

PanTHERA Cryosolutions says it’s secured a $4-million investment from a pair of U.S.-based firms to help get its solution ready for market over the next two years.

‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19

Ottawa biotech firm predicts revenues will top $200 million this year ​– and only rise from there.

Spartan Bioscience says rapid COVID-19 test has Health Canada’s approval

Ottawa company says it plans to begin shipping the device “immediately” to federal and provincial governments as well as commercial customers.

Ottawa biotech startup gets US$1M boost in quest to find treatment for muscle-wasting disease

Scientists at Satellos Bioscience are working on a drug that will help regenerate muscle tissue in patients who suffer from Duchenne muscular dystrophy.

OBJ360 Sponsored

Guest Blogs

Social Galleries

Video

Event Calendar